Title Bar.png

NEWS & EVENTS

 

CALIBRE SCIENTIFIC ACQUIRES KALON BIOLOGICAL AND CLIN-TECH, LEADING PROVIDERS OF IVD MEDICAL DEVICES AND MEDICAL DIAGNOSTIC KITS (October 31, 2018)

Los Angeles, CA (October 31, 2018) – Calibre Scientific is pleased to announce that it has completed the acquisition of Kalon Biological Limited and Clin-Tech Limited (together “KalonBio“ or the “Company”). The Company specializes in the development and manufacture of a range of medical diagnostic kits, commercial ELISA (enzyme immunoassays [EIA]) kits and reagents for the healthcare and life sciences industry.

Kalon Biological is headquartered in Guildford, UK, and is comprised of the following brands: KalonBio, Clin-Tech, and Microimmune. KalonBio specializes in the design and manufacture of in-vitro diagnostic (“IVD”) medical devices and commercial ELISA kits. Clin-Tech provides stains, reagents, and diagnostic kits across a broad product portfolio. And, Microimmune provides IVD products focused on measles, mumps, and rubella testing to hospitals, central testing labs and distribution partners internationally.

“This exciting acquisition adds breadth to our expanding portfolio in the life science tools and diagnostics sector,” said Dr. Ben Travis, CEO of Calibre Scientific. “The products manufactured by KalonBio mesh perfectly with our existing diagnostic platform and broaden our reach within the healthcare, research, pharmaceutical and veterinary industries.”

“We remain committed to continue working closely with our customers and partners to create ever-improving analytics that give us superior vigilance against vaccine-preventable infectious diseases around the world,” stated KalonBio’s Managing Director, Dr. Michael Childerstone.

About Calibre Scientific Inc.

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial and biopharmaceutical communities. The Company is committed to pushing the boundaries of science and innovation through internal expertise combined with strategic acquisitions that help deliver a differentiated and comprehensive set of products, services and support to our customers. Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth our global reach extends into over 53 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

CALIBRE SCIENTIFIC ACQUIRES PHYTOTECH LABS (September 11, 2018)

Los Angeles, CA (September 11, 2018) – Calibre Scientific is pleased to announce that it has completed the acquisition of PhytoTechnology Laboratories, LLC (“PhytoTech Labs“ or the “Company”), a provider of products for plant molecular biology and plant tissue culture research sold throughout the world.

Headquartered in Lenexa, Kansas, PhytoTech Labs is an industry leading provider with a diversified product portfolio including tissue culture media, antibiotics, plant growth regulators, microbiology media, buffers, surfactants, stains and dyes. With over 20 years of experience, the Company has been an industry leader due to its extensive product portfolio, highly consistent media formulation, fast shipping and strong emphasis on customer service and technical support. PhytoTech Labs prioritizes customer satisfaction for its longstanding client base that includes greenhouses, commercial micro-propagation labs, agbiotech research labs, bio-pharma production labs, land grant universities and government agencies.

The acquisition of PhytoTech Labs adds an exceptional niche brand under the Calibre Scientific umbrella that can take advantage of Calibre Scientific’s global sales, marketing, warehousing and distribution capabilities to drive further growth across the world. The Company has established itself as a differentiated provider that possesses several qualities that present long-term value creation opportunities within the group.

“PhytoTech Labs promises to be a unique addition to the Calibre Scientific family,” said Dr. Ben Travis, CEO of Calibre Scientific. “We’re looking forward to combining PhytoTech Labs’ specialized product offerings with our international reach to develop new growth opportunities within the group. Together, Calibre Scientific and PhytoTech Labs will deliver innovative plant-based solutions to customers on a global scale.”

“Calibre Scientific has built a formidable platform that provides a perfect home for PhytoTech Labs as it embarks on the next phase of its growth trajectory,” stated PhytoTech Labs’ Founder and CEO, Dr. Kenneth Torres. “I am impressed by the Calibre Scientific management team philosophy of embracing the unique qualities of each company and building on it which will not only provide our employees great growth opportunities but also help take the Company and the overall customer experience to the next level.”

About Calibre Scientific Inc.

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial and biopharmaceutical communities. The Company is committed to pushing the boundaries of science and innovation through internal expertise combined with strategic acquisitions that help deliver a differentiated and comprehensive set of products, services and support to our customers. Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth our global reach extends into over 53 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

CALIBRE SCIENTIFIC INTRODUCES PRIVACY POLICY (May 30, 2018)

Los Angeles, CA (May 30, 2018) – Calibre Scientific, Inc. respects your concerns about privacy.

Calibre Scientific is made up of different legal entities, details of which can be found here: www.calibrescientific.com. This privacy policy is issued on behalf of the Calibre Scientific Group so when we mention “Calibre Scientific”, “we”, “us” or “our” in this privacy notice, we are referring to the relevant company in the Calibre Scientific Group responsible for processing your data. We will let you know which entity will be the controller when you purchase a product or service with us. Calibre Scientific, Inc. is the controller and responsible for this website.

We have appointed a group data protection officer (“DPO”) who is responsible for overseeing questions in relation to this privacy notice. If you have any questions about this privacy notice, including any requests to exercise your legal rights, please contact the DPO at: enquiries@moleculardimensions.com.

This privacy policy describes how we collect, use, share and protect your personal information and your rights regarding our use.

Information We Collect

Calibre Scientific may collect personally identifiable information including:
-Personal and business contact information (such as name, postal/email address, and telephone number)
-Other personal information you submit to us that is relevant to our business services such as information you provide to register for email alerts

Information We Obtain by Automated Means

Cookies are text files placed on your computer or other internet-connected device to uniquely identify your browser. Calibre Scientific, and certain third-party web provides, may use these and/or similar technology in order to obtain marketing and website analytics. In the event of third-party use information will be disclosed and/or collected by these service providers.

You may choose to block or delete cookies from your browser.

For additional information on cookies please visit www.aboutcookies.org or www.allaboutcookies.org

Data Retention

We will only retain your personal data for as long as necessary to fulfil the purposes we collected it for, including for the purposes of satisfying any legal, accounting, or reporting requirements.

To determine the appropriate retention period for personal data, we consider the amount, nature, and sensitivity of the personal data, the potential risk of harm from unauthorized use or disclosure of your personal data, the purposes for which we process your personal data and whether we can achieve those purposes through other means, and the applicable legal requirements.

Data Security

We have put in place appropriate security measures to prevent your personal data from being accidentally lost, used or accessed in an unauthorized way, altered or disclosed. In addition, we limit access to your personal data to those employees, agents, contractors and other third parties who have a business need to know. They will only process your personal data on our instructions and they are subject to a duty of confidentiality.

We have put in place procedures to deal with any suspected personal data breach and will notify you and any applicable regulator of a breach where we are legally required to do so.

Use of and Purposes for Processing Personal Data

Calibre Scientific processes your personal data in order to comply with our legal and regulatory obligations, our contractual obligations to provide our programs and services to you and/or the legitimate interests of Calibre Scientific, and for other purposes for which Calibre Scientific has a lawful basis under applicable law, including but not limited to: (i) providing our goods and services; (ii) responding to your inquiries; (iii) performing regular business operations; (iv) complying with legal and regulatory requirements; and (iv) participating in litigation, investigations, regulatory or governmental enquiries or for other legal or regulatory purposes involving Calibre Scientific.

If you provide your email address, we may use your email address to send you promotional materials, newsletters and other communications. If you wish to opt out of promotional emails, you may do so by following the “unsubscribe” instructions in the email.

How We Share Collected Information

Calibre Scientific may disclose your personal information with contracted third parties who require the data to perform services based on our legitimate business interests, contractual obligations or with our legal and regulatory requirements.

If you consent, we may share your personal information with our affiliates and subsidiaries so that they may contact you regarding their products and services. If you have consented, you have the right to opt out from marketing communications at a later date.

Data Transfers

Personal information may be transferred to recipients in countries that may not have the same data protection laws as the country in which the information was originally shared. In the event of a transfer, we will ensure data is processed with an adequate level of protection.

Except for those circumstances where we believe that it is appropriate to rely on contractual necessity or your express consent, whenever we transfer your personal data out of the European Economic Area (the “EEA”), we ensure a similar degree of protection is afforded to it by using specific contracts approved by the European Commission which give personal data the same level of protection as it has in the EEA. Please contact us if you require further information on the specific mechanism used by us when transferring your personal data.

Your Rights

You have the right to:
-Request access to your personal data (commonly known as a “data subject access request”). This enables you to receive a copy of the personal data we hold about you and to check that we are lawfully processing it.
-Request correction of the personal data that we hold about you. This enables you to have any incomplete or inaccurate data we hold about you corrected, though we may need to verify the accuracy of the new data you provide to us.
-Request erasure of your personal data. This enables you to ask us to delete or remove personal data where there is no good reason for us continuing to process it. You also have the right to ask us to delete or remove your personal data where you have successfully exercised your right to object to processing (see below), where we may have processed your information unlawfully or where we are required to erase your personal data to comply with local law. Note, however, that we may not always be able to comply with your request of erasure for specific legal reasons which will be notified to you, if applicable, at the time of your request.
-Object to processing of your personal data where we are relying on a legitimate interest (or those of a third party) and there is something about your particular situation which makes you want to object to processing on this ground as you feel it impacts on your fundamental rights and freedoms. You also have the right to object where we are processing your personal data for direct marketing purposes. In some cases, we may demonstrate that we have compelling legitimate grounds to process your information which override your rights and freedoms.
-Request restriction of processing of your personal data. This enables you to ask us to suspend the processing of your personal data in the following scenarios: (a) if you want us to establish the data’s accuracy; (b) where our use of the data is unlawful but you do not want us to erase it; (c) where you need us to hold the data even if we no longer require it as you need it to establish, exercise or defend legal claims; or (d) you have objected to our use of your data but we need to verify whether we have overriding legitimate grounds to use it.
-Request the transfer of your personal data to you or to a third party. We will provide to you, or a third party you have chosen, your personal data in a structured, commonly used, machine-readable format. Note that this right only applies to automated information which you initially provided consent for us to use or where we used the information to perform a contract with you.
-Withdraw consent at any time where we are relying on consent to process your personal data. However, this will not affect the lawfulness of any processing carried out before you withdraw your consent. If you withdraw your consent, we may not be able to provide certain products or services to you. We will advise you if this is the case at the time you withdraw your consent.

You have the right to make a complaint at any time to a supervisory authority in your country. We would, however, appreciate the chance to deal with your concerns before you approach the supervisory authority so please contact us in the first instance.

Access to Your Information

To the extent provided by the law of your jurisdiction, you may request:
-A copy of the data we have on file
-To amend, delete or block information
-To withdraw consent previously provided
-To object, on a legitimate basis, to the processing of your personal information

To update your preferences or submit a request, please contact us as indicated in the “How to Contact Us” section of this Privacy Policy.

Other Websites

Links on our site may lead to outside sources with their own privacy notices or policies, which we suggest you review. The practices outlined in this privacy policy pertain solely to the Calibre Scientific site.

Privacy Policy Updates

Our privacy policy may be updated periodically and without prior notice to you. All changes will be posted on the Calibre Scientific website.

How to Contact Us

If you have questions, comments, concerns or request related to your personal information please contact us using one of the following methods:
-Email: inquiries@calibrescientific.com.
-Telephone: +1 (310) 774-0014
-Mail: Calibre Scientific Data Compliance
2049 Century Park East, Suite 2550
Los Angeles, CA 90067 USA

CALIBRE SCIENTIFIC INTRODUCES DATA PROTECTION POLICY (May 29, 2018)

Los Angeles, CA (May 29, 2018) –

DATA PROTECTION POLICY

Context and Overview

Key Details

Policy prepared by: Dr Claire Naylor
Approved by board/management on: May 25, 2018
Policy became operational on: May 29, 2018
Next review date: 7th February 2019

Introduction

Calibre Scientific, Inc. needs to gather and use certain information about individuals.

These can include customers, suppliers, business contacts, employees and other people the organisation has a relationship with or may need to contact.

This policy describes how this personal data must be collected, handled and stored to meet the company’s data protection standards – and to comply with the law.

Why This Policy Exists

This data protection policy ensures Calibre Scientific:
-Complies with data protection law and follows good practice
-Protects the rights of staff, customers and partners
-Is open about how it stores and processes individuals’ data
-Protects itself from the risks of a data breach

Data Protection Law

The Data Protection Act 1998 (and from 25th May 2018, the GDPR) describes how organisations – including Calibre Scientific – must collect, handle and store personal information.

These rules apply regardless of whether data is stored electronically, on paper or on other materials.

To comply with the law, personal information must be collected and used fairly, stored safely and not disclosed unlawfully.

The Data Protection Act is underpinned by eight important principles. These say that personal data must:
1. Be processed fairly and lawfully
2. Be obtained only for specific, lawful purposes
3. Be adequate, relevant and not excessive
4. Be accurate and kept up to date
5. Not be held for any longer than necessary
6. Processed in accordance with the rights of data subjects
7. Be protected in Appropriate ways
8. Not be transferred outside the European Economic Area (EEA), unless that country or territory also ensures an adequate level of protection

People, risks and responsibilities

Policy Scope

This policy applies to:
-The head office Calibre Scientific
-All portfolio companies of Calibre Scientific
-All staff and volunteers of Calibre Scientific
-All contractors, suppliers and other people working on behalf of Calibre Scientific

It applies to all data that the company holds relating to identifiable individuals, even if that information technically falls outside of the Data Protection Act 1998. This can include:
-Names of individuals
-Postal addresses
-Email addresses
-Telephone numbers
-Any other information relating to individuals

Data Protection Risks

This policy helps to protect Calibre Scientific from some very real data security risks, including:
-Breaches of confidentiality. For instance, information being given out inappropriately.
-Failing to offer choice. For instance, all individuals should be free to choose how the company uses data relating to them.
-Reputational damage. For instance, the company could suffer if hackers successfully gained access to sensitive data.

Responsibilities

Everyone who works for or with Calibre Scientific has some responsibility for ensuring data is collected, stored and handled appropriately.

Each team that handles personal data must ensure that it is handled and processed in line with this policy and data protection principles.

However, these people have key areas of responsibility:
The Board of Directors is ultimately responsible for ensuring that Calibre Scientific meets its legal obligations

The Data Protection Officer, Dr Claire Naylor, is responsible for:
Keeping the Board updated about data protection responsibilities, risks and issues
Reviewing all data protection procedures and related policies, in line with an agreed schedule
Arranging data protection training and advice for the people covered by this policy
Handling data protection questions from staff and anyone else covered by this policy.
Dealing with requests from individuals to see the data Calibre Scientific holds about them (also called ‘subject access requests’).
Checking and approving any contracts or agreements with third parties that may handle the company’s sensitive data.
The IT and website support companies are responsible for:
Ensuring all systems, services and equipment used for storing data meet acceptable security standards.
Performing regular checks and scans to ensure security hardware and software is functioning properly.

The Marketing Manager, Dr Claire Naylor, is responsible for:
Approving any data protection statements attached to communications such as emails and letters.
Addressing any data protection queries from journalists or media outlets like newspapers.
Where necessary, working with other staff to ensure marketing initiatives abide by data protection principles.
Evaluating any third-party services the company is considering using to store or process data. For instance, cloud computing services.

General Staff Guidelines

-The only people able to access data covered by this policy should be those who need it for their work.
-Data should not be shared informally. When access to confidential information is required, employees can request it from their line managers.
-Calibre Scientific will provide training to all employees to help them understand their responsibilities when handling data.
-Employees should keep all data secure, by taking sensible precautions and following the guidelines below.
-In particular, strong passwords must be used and they should never be shared.
-Personal data should not be disclosed to unauthorized people, either within the company or externally.
-Data should be regularly reviewed and updated if it is found to be out of date. If no longer required, it should be deleted and disposed of.
-Employees should request help from their line manager or the data protection officer if they are unsure about any aspect of data protection.

Data Storage

These rules describe how and where data should be safely stored. Questions about storing data safely can be directed to the IT manager or data controller.

When data is stored on paper, it should be kept in a secure place where unauthorised people cannot see it.

These guidelines also apply to data that is usually stored electronically but has been printed out for some reason:
-When not required, the paper or files should be kept in a locked drawer or filing cabinet.
-Employees should make sure paper and printouts are not left where unauthorized people could see them, like on a printer.
-Data printouts should be shredded and disposed of securely when no longer required.

When data is stored electronically, it must be protected from unauthorized access, accidental deletion and malicious hacking attempts:
-Data should be protected by strong passwords that are changed regularly and never shared between employees.
-If data is stored on removable media (like a CD or DVD), these should be kept locked away securely when not being used.
-Data should only be stored on designated drives and servers, and should only be uploaded to an approved cloud computing services.
-Servers containing personal data should be sited in a secure location, away from general office space.
-Data should be backed up frequently. Those backups should be tested regularly, in line with the company’s standard backup procedures.
-Data should never be saved directly to laptops or other mobile devices like tablets or smart phones.
-All servers and computers containing data should be protected by approved security software and a firewall.

Data Use

Personal data is of no value to Calibre Scientific unless the business can make use of it. However, it is when personal data is accessed and used that it can be at the greatest risk of loss, corruption or theft:
-When working with personal data, employees should ensure the screens of their computers are always locked when left unattended.
-Personal data should not be shared informally. In particular, it should never be sent by email, as this form of communication is not secure.
-Data must be encrypted before being transferred electronically. The IT manager can explain how to send data to authorized external contacts.
-Personal data should never be transferred outside of the European Economic Area.
-Employees should not save copies of personal data to their own computers. Always access and update the central copy of any data.

Data Accuracy

The law requires Calibre Scientific to take reasonable steps to ensure data is kept accurate and up to date.

The more important it is that the personal data is accurate, the greater the effort Calibre Scientific should put into ensuring its accuracy.

It is the responsibility of all employees who work with data to take reasonable steps to ensure it is kept as accurate and up to date as possible.

-Data will be held in as few places as necessary. Staff should not create any unnecessary additional data sets.
-Staff should take every opportunity to ensure data is updated. For instance, by confirming a customer’s details when they call.
-Calibre Scientific will make it easy for data subjects to update the information Calibre Scientific holds about them. For instance, via the company website.
-Data should be updated as inaccuracies are discovered. For instance, if a customer can no longer be reached on their stored telephone number, it should be removed from the database.
-It is the marketing manager’s responsibility to ensure marketing databases are checked against industry suppression files every six months.

Subject Access Requests (SAR)

All individuals who are the subject of personal data held by Calibre Scientific are entitled to:
-Ask what information the company holds about them and why.
-Ask how to gain access to it.
-Be informed how to keep it up to date.
-Be informed how the company is meeting its data protection obligations.
-Ask to have their information deleted.
-Request that no further contact

If any individual contacts the company requesting this information, this is called a subject access request.

Subject access requests from individuals should be made by email, addressed to the data controller at enquiries@moleculardimensions.com

The data controller can supply a standard request form, although individuals do not have to use this. The data controller will aim to provide the relevant data within 14 days.

The data controller will always verify the identity of anyone making a subject access request before handing over any information.

Disclosing Data for Other Reasons

In certain circumstances, the Data Protection Act (and the GDPR from 25th May 2018) allows personal data to be disclosed to law enforcement agencies without the consent of the data subject.

Under these circumstances, Calibre Scientific will disclose requested data. However, the data controller will ensure the request is legitimate, seeking assistance from the board and from the company’s legal advisers where necessary.

Providing Information

Calibre Scientific aims to ensure that individuals are aware that their data is being processed, and that they understand:
-How the data is being used
-How to exercise their rights

To these ends, the company has a privacy statement, setting out how data relating to individuals is used by the company.

CALIBRE SCIENTIFIC ACQUIRES BIOZOL DIAGNOSTICA (May 14, 2018)

Los Angeles, CA (May 14, 2018) – Calibre Scientific is pleased to announce that it has completed the acquisition of BIOZOL Diagnostica Vertrieb GmbH (“BIOZOL“ or the “Company”), an independent distributor of life science products across Germany.

Headquartered just outside of Munich, Germany, BIOZOL is one of the largest independent distributors of life science products with a broad offering that spans a variety of innovative suppliers. Its product portfolio of more than 6 million SKUs includes antibodies, proteins, ELISAs, detection kits, biochemicals, reagents and diagnostics kits. Supported by an employee base with deep scientific knowledge, BIOZOL is able to provide a true consultative approach to meet the growing needs of its broad base of customers. This highly diversified client base includes major universities, private and public research institutions, biotechnology, diagnostics and pharmaceutical companies.

“We are excited to add BIOZOL to the Calibre Scientific family as its size and scale in Germany presents actionable growth opportunities for the two companies,” said Ben Travis, CEO of Calibre Scientific. “BIOZOL has built a great reputation in the marketplace over the last 25+ years and we look forward to continuing on that tradition by adding new innovative suppliers to the portfolio to provide a comprehensive solution set with the goal of becoming a single-source provider for our customers.”

“This is an exciting time for all of us,” stated BIOZOL’s Managing Director, Ralf Bäuerle. “The management team at Calibre Scientific shared our vision for driving growth over the coming years and we look forward to leveraging their vast experience in the life sciences industry to help elevate BIOZOL to the next level with the goal of enhancing our capabilities in Germany and beyond.”

About Calibre Scientific Inc.

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics and biopharmaceutical communities. The Company is committed to pushing the boundaries of science and innovation through internal expertise combined with strategic acquisitions that help deliver a differentiated and comprehensive set of products, services and support to our customers. Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth our global reach extends into over 53 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

CALIBRE SCIENTIFIC ACQUIRES PROTEIN ARK AND BIOSERVUK (May 9, 2018)

Los Angeles, CA (May 9, 2018) – Calibre Scientific is pleased to announce that it has completed the acquisitions of Protein Ark and BioServUK (together the “Companies“), providers of custom and off-the-shelf proteins, antibodies and other products utilized by the academic life science research and diagnostics communities. The inclusion of BioServUK and Protein Ark allows the group-at-large to offer a comprehensive gene-to-structure service to customers, while creating entry points for Calibre Scientific into the ever-growing antibody space.

Based in Sheffield, United Kingdom, BioServUK is a specialist contract research and manufacturing organization with expertise in the production and processing of bio-molecules, primarily specialty antibodies for research, biotech, pharma, and in-vitro diagnostic manufacturers. Beyond its contract services, BioServUK is also in the midst of developing a new life sciences research database search engine called OEEEY. This new technological asset will enable users to look up specific studies related to a particular antibody or protein in an effort to reduce research time and speed up customer workflow.

Protein Ark is also based in Sheffield and offers a comprehensive range of sample preparation products, separation kits, and custom services to help streamline and advance customer research from clone-to-protein and peptide-to-antibody.

“We are excited to add BioServUK and Protein Ark to the portfolio as they enable Calibre Scientific to expand its capabilities in the specialty protein and antibody space,” states Calibre Scientific’s CEO, Ben Travis. “The acquisition further bolsters our presence in the United Kingdom and provides a strong foundation to service our customers across Europe. Additionally, these companies will enhance Calibre Scientific’s presence in the proteomics vertical, which already includes detergent and lipids leader, Anatrace, and crystallography specialist, Molecular Dimensions.”

BioServUK and Protein Ark Managing Director, Mike Brownleader, is excited about the possibilities this new collaboration provides. “Joining Calibre Scientific gives us a chance to offer our clients an even broader scope of products and services, while providing tremendous growth opportunities for our companies and employees.” As part of the acquisition, Mike Brownleader will take on a broader role within Calibre Scientific to work closely with the various portfolio companies with the goal of capitalizing on market opportunities across Europe by enhancing organic go-to-market strategy as well as identifying acquisition targets with innovative complementary technologies.

About Calibre Scientific Inc.

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics and biopharmaceutical communities. The Company is committed to pushing the boundaries of science and innovation through internal expertise combined with strategic acquisitions that help deliver a differentiated and comprehensive set of products, services and support to our customers. Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth our global reach extends into over 53 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

STONECALIBRE LAUNCHES CALIBRE SCIENTIFIC (January 1, 2018)

Los Angeles, CA (January 1, 2018) – StoneCalibre is pleased to announce the formation of Calibre Scientific, Inc., a Delaware holding company, which will be a consolidation vehicle in the healthcare life sciences industry under the leadership of Ben Travis as its Chief Executive Officer. As part of the Company’s formation, StoneCalibre contributed the six life sciences acquisitions it has made over the last four years that, today, collectively represent a diversified portfolio in the life science tools and diagnostics sector.

“This represents the crystallization of a strategy that we embarked upon starting with the acquisition of Anatrace in late 2013,” said Brian Wall, Founder and CEO of StoneCalibre. “We have a long-term view on building a company that can be a leading global provider of life science products and services to scientists and researchers all over the world.”

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

STONECALIBRE AFFILIATE ACQUIRES ALPHA-TEC SYSTEMS (July 19, 2017)

Los Angeles, CA (July 19, 2017) – StoneCalibre is pleased to announce that one of its affiliates has completed the acquisition of Alpha-Tec Systems, Inc., a Vancouver, WA based provider of in-vitro diagnostic products utilized by clinical laboratories in the disciplines of mycobacteriology, parasitology, bacteriology and mycology.

“We are pleased to welcome Alpha-Tec to the StoneCalibre family,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “Alpha-Tec has maintained a first-class reputation in the mycobacteriology space for over 35 years. We are excited to partner with a Company that enables the global medical community to accurately diagnose and timely treat infectious diseases, such as latent tuberculosis, to help elevate the quality of human life.”

Founded in 1979, Alpha-Tec is the leading provider of proprietary digestion, decontamination, neutralization and other sample preparation products for mycobacteria diagnostics that improve laboratory test results and are compatible with a variety of downstream testing methodologies. Alpha-Tec is well-respected in the marketplace for its high-quality products as well as its exceptional customer service.

“Alpha-Tec serves a valuable customer base that includes the top hospital, reference and public health laboratories across the United States and abroad,” said Usman Shakeel, Vice President of StoneCalibre. “We see actionable opportunities for the Company to grow organically and via add-on acquisitions to better serve the clinical lab space.”

“Alpha-Tec has a proud history of being a family-run business and as we move toward the next phase in the Company’s evolution, it is important for us to partner with someone who understands our history and shares in our vision for Alpha-Tec’s future,” said Chris Williams, Chief Executive Officer of Alpha-Tec. “We are very excited to partner with StoneCalibre and its affiliates in the life sciences industry based on their knowledge of the space, operational resources and geographic reach which will contribute toward accelerating Alpha-Tec’s growth going forward and advance our broader mission of improving patient care through diagnostics.”

About StoneCalibre

Headquartered in Los Angeles, CA, StoneCalibre is a private investment company specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. For more information please visit our website at www.stonecalibre.com.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

STONECALIBRE PORTFOLIO COMPANY ACQUIRES MOLECULAR DIMENSIONS (February 14, 2017)

Los Angeles, CA (February 14, 2017) – StoneCalibre is pleased to announce that its portfolio company, Anatrace, has completed the acquisition of Molecular Dimensions Ltd. (“Molecular Dimensions” or the “Company”), a Cambridge, UK based leading supplier of modern screens, reagents, other consumables and instrumentation for structural biology research.

“We are pleased to add Molecular Dimensions to the Anatrace family as it establishes the European presence for the group and further solidifies its position in the structural biology arena,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “We will continue to look for additional strategic acquisitions in the life science tools and diagnostics industry that could enhance the geographic presence, bolster the product and service offering and complement the organic growth of the companies.”

Founded in 1998 to provide specialist products for crystallographers, Molecular Dimensions has grown through alliances with leading scientists aimed at developing and commercializing innovative ideas. The Company serves clients operating in structural biology research across Europe, the Americas and Asia in universities, research institutes, and blue-chip corporates focused on drug discovery.

“Most of us may understand that drug discovery is a long and arduous multi-year process, but what is less known is that many of the specific drug targets are proteins. With the addition of Molecular Dimensions we will be able to offer a more complete portfolio of tools that aid and support drug discovery, disease prevention and cure,” said Ben Travis, Chief Executive Officer of Anatrace. “We are excited to continue to invest in technologies that remain at the cutting edge of this evolving industry.”

“As I evaluated a variety of potential strategic alternatives for Molecular Dimensions, it quickly became evident that partnering with Anatrace and StoneCalibre was the ideal path forward,” said Tony Savill, Founder and Managing Director of Molecular Dimensions. “Their industry expertise, growth-oriented mind-set and our strategic fit with Anatrace convinced me that Molecular Dimensions would continue to thrive under their leadership for years to come.”

About StoneCalibre

Headquartered in Los Angeles, CA, StoneCalibre is a private investment company specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. For more information please visit our website at www.stonecalibre.com.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

STONECALIBRE ACQUIRES ION CHROMATOGRAPHY BUSINESS (September 10, 2015)

Los Angeles, CA (September 10, 2015) – StoneCalibre, LLC is pleased to announce that one of its affiliates, Edge BioSystems, Inc., has acquired the Ion Chromatography Business from Transgenomic, Inc. (NASDAQ: TBIO). The Company, which will be renamed Concise Separations, is based in San Jose, CA, and is responsible for researching, developing, manufacturing, and marketing high quality bulk resins and high performance liquid chromatography (“HPLC”) columns with applications across diverse fields such as pharmaceuticals, foods, life sciences, environmental, and forensics.

Ion chromatography (“IC”) is a chemical analysis technique that separates and analyzes different substances according to their affinities for chemically stable, highly reactive, synthetic ion exchangers. Transgenomic’s IC product line includes a wide range of specialty ion chromatography columns that are designed to run on a variety of HPLC platforms.

“We have been impressed by the vision, dedication and expertise of the employee base of the Ion Chromatography Business and look forward to partnering with them in the next phase of the Company’s development,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “As a division of EdgeBio, we intend to work with the Company by increasing investments in R&D, sales and marketing and ultimately helping them unlock their full potential.”

“As we assessed our strategic alternatives for the Ion Chromatography Business, StoneCalibre’s history of executing carve-out transactions and their experience in the life sciences industry made them a natural buyer for the business,” said Paul Kinnon, Chief Executive Officer of Transgenomic. “We are pleased with the transaction and believe StoneCalibre will provide a great home for the business and its employees going forward.”

About StoneCalibre

Headquartered in Los Angeles, CA, StoneCalibre is a private investment company specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. For more information please visit our website at www.stonecalibre.com.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

STONECALIBRE PORTFOLIO COMPANY ACQUIRES MICROLYTIC (January 6, 2015)

Los Angeles, CA (January 6, 2015) – StoneCalibre is pleased to announce that its portfolio company, Anatrace, has completed the acquisition of Microlytic, a provider of innovative life science tools and reagents to the structural biology market. Microlytic’s solutions represent the most productive approaches to soluble protein crystallization, which allow researchers to accelerate workflow, increase output quality and help solve the major problem in structural biology: crystal formation.

“Microlytic will add to Anatrace’s market leading portfolio of high-purity detergents and synthetic lipids, including the co-developed Analytic product line,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “We will continue to look for strategic acquisitions, such as Microlytic, to supplement Anatrace’s organic growth and as a means to broaden our product offering and expand our customer base.”

Dr. Ben Travis, CEO of Anatrace, expressed his enthusiasm for the transaction. “We have been impressed by the Microlytic team and their track record of innovation in the structural biology market and look forward to working together towards achieving the high standards that have come to define Anatrace.” Dr. Travis stated, “With the acquisition of Microlytic we are able to deliver a comprehensive and innovative set of solutions that will further advance the important field of protein biology research.”

The terms of the transaction were not disclosed.

About StoneCalibre

Headquartered in Los Angeles, CA, StoneCalibre is a private investment company specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. For more information please visit our website at www.stonecalibre.com.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

STONECALIBRE ACQUIRES EDGE BIOSYSTEMS (July 8, 2014)

Los Angeles, CA (July 8, 2014) – StoneCalibre announced today the completion of the acquisition of Edge Biosystems, Inc. (“EdgeBio”), headquartered in Gaithersburg, Maryland. Established in 1990, EdgeBio is a highly specialized manufacturer and distributor of sample preparation and clean-up products for use in DNA sequencing.

EdgeBio’s consumable products are critical components in the DNA sequencing process allowing researchers to determine the exact genetic make-up of DNA for use in clinical and diagnostic labs, food testing, molecular medicine, ancestry studies and other applications. EdgeBio has built a solid reputation as a sequencing purification supplier of choice stemming from its consistent, high-quality product performance backed by its proprietary formulations.

“We are extremely pleased to announce the EdgeBio transaction and are thrilled about the opportunity to play a role in the rapidly developing DNA sequencing industry as it works to help solve real world issues from detecting foodborne illnesses before they spread to discovering how we can prevent and treat diseases,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “We believe EdgeBio will continue to build on its tradition of providing high-quality, easy-to-use products to its global customer base and serve as a strong platform for future growth.”

John Seed, Founder and President of EdgeBio, expressed his enthusiasm for partnering with StoneCalibre. “Having built this company for the last 23 years it was important for me to find the right transaction partner that I felt had the skill set and resources to take EdgeBio to the next level.” Mr. Seed, who will continue in the role as President stated, “I’m truly looking forward to the collaboration with StoneCalibre going forward.”

BroadOak Capital Partners acted as the exclusive sell-side financial advisor in this transaction. The terms of the transaction were not disclosed.

About StoneCalibre

Headquartered in Los Angeles, CA, StoneCalibre is a private investment company specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. For more information please visit our website at www.stonecalibre.com.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.

STONECALIBRE ACQUIRES ANATRACE FROM AFFYMETRIX (October 14, 2013)

Los Angeles, CA (October 14, 2013) – StoneCalibre today announced the completion of the acquisition of Anatrace, a part of Affymetrix, Inc. (NASDAQ: AFFX). Headquartered in Maumee, Ohio, Anatrace is a highly specialized developer, manufacturer and global distributor of unique, high purity detergents and synthetic lipids for use in membrane protein studies.

Established in 1985, Anatrace has built the broadest portfolio of detergents and lipids available in the marketplace with a core competency of developing and manufacturing creative solutions for stabilizing and solubilizing macromolecules.

“Anatrace is a high quality company offering a value-add product that is mission critical to its customer base,” said Brian Wall, Founder and Chief Executive Officer of StoneCalibre. “We are confident that as a standalone company, Anatrace will continue to build on its tradition of collaborating with its global customer base to help answer critical questions in the advancement of important studies across multiple scientific fields including cancer research.”

“StoneCalibre has been a great partner for us through this process,” said Frank Witney, Chief Executive Officer of Affymetrix. “Their corporate carve-out experience and ability to offer speed and certainty around the sale process were critical factors for us. We feel that StoneCalibre will provide a great long-term home for Anatrace and its devoted employee base.”

Ben Travis, the newly appointed CEO of Anatrace, expressed his enthusiasm for partnering with StoneCalibre. “Anatrace’s passion for detergents and lipids, combined with StoneCalibre’s strategic and financial support, will help drive the company to higher levels of excellence and allow us to capitalize on future growth opportunities.”

Anatrace is StoneCalibre’s second acquisition in the last five months. The terms of the transaction were not disclosed. EMA Partners acted as the exclusive financial advisor to Affymetrix.

About StoneCalibre

Headquartered in Los Angeles, CA, StoneCalibre is a private investment company specializing in the acquisition of lower middle market companies. Founded by Brian Wall in 2012, StoneCalibre is focused on making investments in both special situations and quality long-term capital investment opportunities. For more information please visit our website at www.stonecalibre.com.

For more information, visit www.calibrescientific.com, or contact Dr. Matthew Lorence, SVP, Marketing, mclorence@calibrescientific.com.